Abstract:Summary
In the present work, the production of poly(methyl methacrylate‐co‐acrylic acid), P(MMA‐co‐AA), nanoparticles and the subsequent functionalization through immobilization of BSA (bovine serum albuminum) and lysine were investigated. Nanoparticles produced presented average size of 100 nm, zeta potential of −40 mV and AA content ranging from 1 to 10 mol%. Particularly, it was shown that inespecific physical interactions control the adsorption of BSA onto the particle surfaces. On the other hand, lysine w… Show more
“…These concentrations were defined in accordance with previous MMA miniemulsion polymerization studies. [8,16,29,30] The initial miniemulsions were prepared with a sonifier (Branson 450, Marshall Scintific, Hampton, USA) at 160 W for 5 min or with an ultra-turrax (T10 basic, IKA, Staufen, Germany) for 5 min at 14,500 rpm, using an ice bath to control the temperature of the emulsified system and keep it close to room temperature. The polymerizations were conducted in a 100 mL glass reactor (EasyMax 102, Mettler Toledo, Ohio, USA) at 80 o C under the agitation of 500 rpm for 180 min.…”
The present work evaluated the effects of different ionic and nonionic stabilizers and respective concentrations on methyl methacrylate (MMA) miniemulsion polymerizations. The stabilities of the prepared miniemulsions are characterized through sedimentation and phase separation analyses and afterwards polymerizations are performed at the most stable conditions for each analyzed stabilizer. Monomer conversion profiles and final product properties are determined for comparative purposes. Obtained results indicated that the performances of the stabilizers during the polymerizations are not necessarily related to the stabilizing performances observed during preparation of the miniemulsions and that polymer latexes produced with the nonionic surfactant Tween80 presented the most suitable properties for applications in the biomedical field, as this stabilizer presented good stabilizing performances both during miniemulsion preparation and miniemulsion polymerization.
“…These concentrations were defined in accordance with previous MMA miniemulsion polymerization studies. [8,16,29,30] The initial miniemulsions were prepared with a sonifier (Branson 450, Marshall Scintific, Hampton, USA) at 160 W for 5 min or with an ultra-turrax (T10 basic, IKA, Staufen, Germany) for 5 min at 14,500 rpm, using an ice bath to control the temperature of the emulsified system and keep it close to room temperature. The polymerizations were conducted in a 100 mL glass reactor (EasyMax 102, Mettler Toledo, Ohio, USA) at 80 o C under the agitation of 500 rpm for 180 min.…”
The present work evaluated the effects of different ionic and nonionic stabilizers and respective concentrations on methyl methacrylate (MMA) miniemulsion polymerizations. The stabilities of the prepared miniemulsions are characterized through sedimentation and phase separation analyses and afterwards polymerizations are performed at the most stable conditions for each analyzed stabilizer. Monomer conversion profiles and final product properties are determined for comparative purposes. Obtained results indicated that the performances of the stabilizers during the polymerizations are not necessarily related to the stabilizing performances observed during preparation of the miniemulsions and that polymer latexes produced with the nonionic surfactant Tween80 presented the most suitable properties for applications in the biomedical field, as this stabilizer presented good stabilizing performances both during miniemulsion preparation and miniemulsion polymerization.
“…[5,24,25] Miniemulsion polymerizations have been used extensively for manufacture of polymer nanoparticles. [26][27][28] This technique presents many competitive advantages, including the fact that use of toxic solvents is not necessary, the high stability of obtained polymer latex and the possibility to perform the encapsulation of chemicals in situ. A typical formulation comprises two phases: the dispersant aqueous phase and the emulsified organic phase, which contains monomers and co-stabilizers.…”
Schistosomiasis is a neglected tropical disease that affects primarily the poorest and most vulnerable populations. Although praziquantel (PZQ) is the drug used most frequently for treatment of schistosomiasis, PZQ presents unpleasant bitter taste and low solubility in water, which prejudice the implementation of pediatric treatments. For this reason, the main purpose of the present work was the production of stable nanoparticles loaded with PZQ through in situ miniemulsion copolymerizations of methyl methacrylate (MMA) with diethylaminoethyl methacrylate (DEAEMA) or dimethylaminoethyl methacrylate (DMAEMA). Due to the cationic nature of the comonomers, the use of different ionic surfactants was also investigated. Nanoparticles with narrow particle size distributions, characteristic average diameters ranging from 50 nm to 110 nm, and loaded with 20 wt% of PZQ were manufactured successfully PZQ encapsulation efficiencies were higher than 97 wt% and PZQ was homogeneously dispersed in the final polymer matrix. Finally, the use of a cationic surfactant with DEAEMA cationic comonomer led to more stable latexes because of the high absolute value of the zeta potential.
“…First of all, it is important to emphasize that previous works investigated the manufacture of P(MMA‐co‐AA) nanoparticles at distinct conditions and using different AA concentrations,29,38 reporting the copolymer compositions (obtained through nuclear magnetic resonance analyses) and molar mass distributions (obtained through gel permeation chromatography) of the obtained nanoparticles. Besides, scanning electron microscopy (SEM) analyses of the obtained P(MMA‐co‐AA) nanoparticles showed that the obtained particles were spherical, with average sizes of 100 nm and presenting very narrow size distributions 32. According to the recipe presented in Table 1, the final AA content of the obtained copolymer was equal to 1 mol% and the weight‐average molar mass was equal to 1.3 × 10 3 kg mol −1 , with polydispersity of 2.0, as also reported previously.…”
Polymer nanoparticles produced through miniemulsion polymerizations can be used for design of drug encapsulation and targeted delivery systems. Particularly, the immobilization of functional groups on the surfaces of polymeric nanoparticles enables the development of targeted delivery systems, intended for particle absorption by specific body tissues, favoring the treatment of diseases. For this reason, in the present work poly(methyl methacrylate-co-acrylic acid) (P(MMA-co-AA)) nanoparticles loaded with clioquinol are prepared through in situ miniemulsion polymerizations for the first time. Besides, nanoparticles are functionalized with a cell-penetrating trans-activating transcriptor (TAT) peptide for the first time, to show that incorporation of carboxylic groups (from acrylic acid (AA)) on the particle surfaces provides an effective route for functionalization of nanoparticles with biomolecules. Particularly, it is shown that spherical particles with average sizes between 60 and 100 nm and zeta potential of −50 mV are produced and that the TAT peptide is successfully immobilized onto the particle surfaces. Besides, it is also shown that the clioquinol encapsulation efficiency is equal to 97%. In vitro tests show that 50% of the initial load of clioquinol is released after 9 h of test.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.